Skip to content

EFFECT OF CASTOR OIL ON PRE-INDUCTION CERVICAL RIPENING OF TERM PREGNANCIES

Effect Of Castor Oil With Vaginal Misoprostol Versus Vaginal Misoprostol Alone On Pre-Induction Cervical Ripening Of Term Pregnancies In Enugu, Nigeria: A Randomised Controlled Trial.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202409731074866
Enrollment
177
Registered
2024-09-23
Start date
2023-12-20
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

MISOCASTOR
MISOPROSTOL

Sponsors

Eze Jeremiah Ugochukwu
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Consenting singleton pregnant women at term Those with unfavourable cervix booked for induction of labour at the study centers.

Exclusion criteria

Exclusion criteria: History of previous uterine scar (C-section or myomectomy) Refusal of consent

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the median induction delivery interval between term pregnant women that received a combination of vaginal misoprostol 25 µg and oral castor oil 60 ml versus vaginal misoprostol 25 µg alone at the tertiary hospitals in Enugu, Nigeria

Secondary

MeasureTime frame
Incidence of cervical ripening in tertiary hospitals in Enugu, Incidence of failed induction between the two groups, Compare adverse maternal/neonatal complications between the 2 groups

Countries

Nigeria

Contacts

Public ContactProf. Euzebus .C. Ezugwu

Chairman health research ethis committee

euzebus.ezugwu@unn.edu.ng+23408037020295

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026